- Home
- ACNB vs AQST Comparison
ACNB vs AQST Comparison
Compare ACNB & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- AQST
- Stock Information
- Founded
- ACNB 1857
- AQST 2004
- Country
- ACNB United States
- AQST United States
- Employees
- ACNB N/A
- AQST N/A
- Industry
- ACNB Major Banks
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- ACNB Finance
- AQST Health Care
- Exchange
- ACNB Nasdaq
- AQST Nasdaq
- Market Cap
- ACNB 450.1M
- AQST 390.4M
- IPO Year
- ACNB N/A
- AQST 2018
- Fundamental
- Price
- ACNB $44.89
- AQST $5.08
- Analyst Decision
- ACNB Strong Buy
- AQST Strong Buy
- Analyst Count
- ACNB 3
- AQST 7
- Target Price
- ACNB $50.00
- AQST $10.29
- AVG Volume (30 Days)
- ACNB 19.2K
- AQST 2.6M
- Earning Date
- ACNB 10-23-2025
- AQST 11-03-2025
- Dividend Yield
- ACNB 3.03%
- AQST N/A
- EPS Growth
- ACNB N/A
- AQST N/A
- EPS
- ACNB 2.69
- AQST N/A
- Revenue
- ACNB $123,053,000.00
- AQST $44,132,000.00
- Revenue This Year
- ACNB $40.40
- AQST N/A
- Revenue Next Year
- ACNB $4.84
- AQST $38.71
- P/E Ratio
- ACNB $16.69
- AQST N/A
- Revenue Growth
- ACNB 15.31
- AQST N/A
- 52 Week Low
- ACNB $35.70
- AQST $2.12
- 52 Week High
- ACNB $50.72
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- ACNB 51.76
- AQST 67.17
- Support Level
- ACNB $44.20
- AQST $4.75
- Resistance Level
- ACNB $45.47
- AQST $5.60
- Average True Range (ATR)
- ACNB 0.67
- AQST 0.29
- MACD
- ACNB -0.14
- AQST 0.10
- Stochastic Oscillator
- ACNB 37.37
- AQST 72.49
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.